Article
To protect against the threat of counterfeit drugs, the Food and Drug Administration wants drug makers, distributors, and pharmacists to adopt new technologies, including embedded computer chips that wound transmit identifying information, by 2007.
Dermatology Times November 2024 Print Recap
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Advances in HS treatment with Chris Sayed, MD
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
New Hydroquinone Pigmentation Alternatives
Polynucleotide Therapy Shows Promise in Scar and Burn Management